Full text
PDFPage 514
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Citron K. M. BCG vaccination against tuberculosis: international perspectives. BMJ. 1993 Jan 23;306(6872):222–223. doi: 10.1136/bmj.306.6872.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Etemadi A., Farid R., Stanford J. L. Immunotherapy for drug-resistant tuberculosis. Lancet. 1992 Nov 28;340(8831):1360–1361. doi: 10.1016/0140-6736(92)92551-p. [DOI] [PubMed] [Google Scholar]
- Nye P. M., Price J. E., Revankar C. R., Rook G. A., Stanford J. L. The demonstration of two types of suppressor mechanism in leprosy patients and their contacts by quadruple skin-testing with mycobacterial reagent mixtures. Lepr Rev. 1983 Mar;54(1):9–18. doi: 10.5935/0305-7518.19830002. [DOI] [PubMed] [Google Scholar]
- Rook G. A., al Attiyah R. Cytokines and the Koch phenomenon. Tubercle. 1991 Mar;72(1):13–20. doi: 10.1016/0041-3879(91)90019-o. [DOI] [PubMed] [Google Scholar]
- Stanford J. L., Shield M. J., Rook G. A. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle. 1981 Mar;62(1):55–62. doi: 10.1016/0041-3879(81)90037-4. [DOI] [PubMed] [Google Scholar]